Cargando…

Investigation of the Mechanism of Shengmai Injection on Sepsis by Network Pharmacology Approaches

Shengmai injection (SMI) contains Ginsen Radix et Rhizoma Rubra, Ophiopogon japonicus, and Schisandrae Chinensis Fructus. It is used as a supportive herbal medicine in the management of sepsis, systemic inflammatory response syndrome, and septic or hemorrhagic shock. An UPLC method was established t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Juan, Lyu, Xinkai, Chai, Ruiping, Yu, Yue, Deng, Minghui, Zhan, Xia, Dong, Zhengqi, Chen, Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422069/ https://www.ncbi.nlm.nih.gov/pubmed/32831866 http://dx.doi.org/10.1155/2020/4956329

Ejemplares similares

Prediction the Molecular Mechanism of Shengmai Injection in Acute Treatment of COVID-19 Based on Network Pharmacology
por: Wang, Chen, et al.
Publicado: (2022)

Efficacy and safety of Shengmai injection as an adjunctive therapy on sepsis: A protocol for systematic review and meta-analysis
por: Han, Yue, et al.
Publicado: (2022)

The Inhibition of the Components from Shengmai Injection towards UDP-Glucuronosyltransferase
por: Jiang, Li-Peng, et al.
Publicado: (2014)

A Metabolomic Study of Rats with Doxorubicin-Induced Cardiomyopathy and Shengmai Injection Treatment
por: Chen, Yu, et al.
Publicado: (2015)

In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity
por: Zhou, Peng, et al.
Publicado: (2022)

Mechanism of Action of Dengzhan Shengmai in Regulating Stroke from an Inflammatory Perspective: A Preliminary Analysis of Network Pharmacology
por: Yan, Yiqi, et al.
Publicado: (2021)

Exploring the mechanism of Shengmai Yin for coronary heart disease based on systematic pharmacology and chemoinformatics
por: Jiang, Yan, et al.
Publicado: (2020)

Clinical evidence-guided network pharmacology analysis reveals a critical contribution of β1-adrenoreceptor upregulation to bradycardia alleviation by Shenxian-Shengmai
por: Gao, Jiaming, et al.
Publicado: (2019)

Use of a Systematic Pharmacological Methodology to Explore the Mechanism of Shengmai Powder in Treating Diabetic Cardiomyopathy
por: Zhang, Shi-ying, et al.
Publicado: (2020)

Evaluation of Potential Herb-Drug Interactions Between Shengmai Injection and Losartan Potassium in Rat and In Vitro
por: Niu, Zhenchao, et al.
Publicado: (2022)

Efficacy and Safety of Shengmai Injection for Chronic Heart Failure: A Systematic Review of Randomized Controlled Trials
por: Wang, Yanping, et al.
Publicado: (2020)

Effect of Shengmai Yin on Epithelial-Mesenchymal Transition of Nasopharyngeal Carcinoma Radioresistant Cells
por: Wang, Ze-tai, et al.
Publicado: (2022)

The effect of Shengmai injection in patients with coronary heart disease in real world and its personalized medicine research using machine learning techniques
por: Ma, Jing, et al.
Publicado: (2023)

A Metabolomics-Based Strategy for the Quality Control of Traditional Chinese Medicine: Shengmai Injection as a Case Study
por: Li, Xiaodong, et al.
Publicado: (2013)

Shengmai Injection, a Traditional Chinese Patent Medicine, for Intradialytic Hypotension: A Systematic Review and Meta-Analysis
por: Chen, Chao-yang, et al.
Publicado: (2013)

Shengmai San Ameliorates Myocardial Dysfunction and Fibrosis in Diabetic db/db Mice
por: Zhao, Juan, et al.
Publicado: (2016)

Shengmai Injection Improved Doxorubicin-Induced Cardiomyopathy by Alleviating Myocardial Endoplasmic Reticulum Stress and Caspase-12 Dependent Apoptosis
por: Chen, Yu, et al.
Publicado: (2015)

Shengmai Yin formula modulates the gut microbiota of spleen-deficiency rats
por: You, Yu, et al.
Publicado: (2020)

A Quantitative Serum Proteomic Analysis Helps to Explore the Comprehensive Mechanism and Identify Serum Biomarkers of Shengmai Injection’s Effect on Isoproterenol-Induced Myocardial Ischemia in Rats
por: Zhang, Xiaoping, et al.
Publicado: (2021)

Shengmai injection inhibits palmitic acid-induced myocardial cell inflammatory death via regulating NLRP3 inflammasome activation
por: Yin, Gang, et al.
Publicado: (2023)

Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation
por: Li, Lin, et al.
Publicado: (2020)

Investigation of the Mechanisms of Chuankezhi Injection in the Treatment of Asthma Based on the Network Pharmacology Approach
por: Zhu, Hao, et al.
Publicado: (2021)

Increased serum protein levels by Yuanshi Shengmai Chenggu Tablet in treatment of avascular osteonecrosis of the femoral head
por: Zeng, Jianchun, et al.
Publicado: (2018)

A Strategy for Selecting “Q-Markers” of Chinese Medical Preparation via Components Transfer Process Analysis with Application to the Quality Control of Shengmai Injection
por: Zhao, Chunxia, et al.
Publicado: (2019)

Shengmai injection combined with conventional therapy in treating Adriamycin-related cardiotoxicity: A protocol for systematic review and meta-analysis of randomized controlled trials
por: Liu, Lanchun, et al.
Publicado: (2020)

Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms
por: Li, Yiping, et al.
Publicado: (2019)

Pharmacokinetic Compatibility of Ginsenosides and Schisandra Lignans in Shengmai-san: From the Perspective of P-Glycoprotein
por: Liang, Yan, et al.
Publicado: (2014)

Therapeutic Mechanism and Key Active Ingredients of Shenfu Injection in Sepsis: A Network Pharmacology and Molecular Docking Approach
por: Yuan, Huajing, et al.
Publicado: (2022)

Interaction between Warfarin and the Herbal Product Shengmai-Yin: A Case Report of Intracerebral Hematoma
por: Su, Qun, et al.
Publicado: (2010)

Effect of Shengmai Yin on the DNA methylation status of nasopharyngeal carcinoma cell and its radioresistant strains
por: Liu, Shiya, et al.
Publicado: (2021)

Effect of repeated Shengmai-San administration on nifedipine pharmacokinetics and the risk/benefit under co-treatment
por: Wang, Hong-Jaan, et al.
Publicado: (2022)

Network pharmacology to investigate the pharmacological mechanisms of muscone in Xingnaojing injections for the treatment of severe traumatic brain injury
por: Liu, Zhuohang, et al.
Publicado: (2021)

Network Pharmacology Study on the Pharmacological Mechanism of Cinobufotalin Injection against Lung Cancer
por: Mao, Yun, et al.
Publicado: (2020)

Screening of Serum Protein Markers for Avascular Osteonecrosis of Femoral Head Differentially Expressed after Treatment with Yuanshi Shengmai Chenggu Tablets
por: Deng, Peng, et al.
Publicado: (2018)

ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress
por: Lu, Yanting, et al.
Publicado: (2021)

Investigating the multi-target pharmacological mechanism of danhong injection acting on unstable angina by combined network pharmacology and molecular docking
por: Guo, Siyu, et al.
Publicado: (2020)

Shenxian-Shengmai Oral Liquid Improves Sinoatrial Node Dysfunction through the PKC/NOX-2 Signaling Pathway
por: Zhang, Heng, et al.
Publicado: (2021)

Huangqi Shengmai Yin Ameliorates Myocardial Fibrosis by Activating Sirtuin3 and Inhibiting TGF-β/Smad Pathway
por: Pan, Jianheng, et al.
Publicado: (2021)

Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism
por: Cao, Zhanhong, et al.
Publicado: (2021)

Shenxian-Shengmai Oral Liquid Evoke Autophagy of Fibroblast to Attenuate Sinoatrial Node Fibrosis in Sick Sinus Syndrome Mice via the AKT/mTOR Pathway
por: Chen, Chen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qv8tph2mbjeeecboucthro7k5l